Discovery To Commence In Invitrogen Patent Case

Law360, New York (October 4, 2007, 12:00 AM EDT) -- Life sciences company Invitrogen Corp. has won the go-ahead to commence limited discovery in a lawsuit that accuses Harvard College's top guardians of wrongly laying claim to a molecular cloning patent.

In an order issued Thursday, Magistrate Judge Louisa S. Porter of the U.S. District Court for the Southern District of California said Invitrogen was not required to establish a prima facie case of personal jurisdiction prior to conducting discovery.

However, she did say Invitrogen's discovery requests were overly burdensome, and therefore partially granted Harvard's motion...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.